23andme
Meet Color Genomics, the Startup That Wants to Make Genetic Testing Less Expensive
The Silicon Valley startup just raised $15 million in funding from PayPal co-founder Max Levchin, Yahoo's Jerry Yang and other high-profile investors.
FDA Grants 23andMe Approval to Sell Test for Rare Genetic Condition
It's a small but definite step towards 23andMe's goal of selling DNA kits again.
23andMe's Database of Genetic Information Is Going to Make It Lots of Money
The company just announced a lucrative deal with the biotech firm Genetech, and says many similar deals are in the works.
How 23andMe Caused a Divorce: A Look at Unintended Consequences
A look at what happens when customers use a business for their own purposes, regardless of the company's explicit mission.
Google Wants to Build a Model of Perfect Human Health
Big data, meet genetic data. Baseline Study, a Google X project, will collect genetic information from volunteers in order to refine the detection and prevention of diseases.
Google Is Interested in Your Health, But Deterred by Regulations
In an extensive interview with venture capitalist Vinod Khosla, Google founders Sergey Brin and Larry Page explained why regulations are hampering improvements in health care.
In Taking Aim at 23andMe, Regulators Missed the Mark
The controversy over genetic-testing company 23andMe begs the question: Is knowledge really that dangerous?
FDA Tells 23andMe to Quit Selling Genetic Testing Kits
The Food and Drug Administration said the popular genetics testing kits are being sold without 'marketing clearance or approval.'
